THE TRIFECTA: A NOVEL COMBINATORIAL THERAPY SPARES IMMUNE CELLS WHILE INDUCING IMMUNOGENIC CELL DEATH IN HUMAN MAMMARY ADENOCARCINOMA AND MOUSE MAMMARY CARCINOMA

According to U.S. Breast Cancer Statistics, about 1 in 8 U.S. women will develop invasive breast cancer during their lifetime. Chemotherapeutics that are used on patients currently often lead to tumor resistance, bone marrow suppression and cachexia. This study evaluated a novel combination of three...

Full description

Bibliographic Details
Other Authors: Motii, Youssef (author)
Format: Others
Language:English
Published: Florida Atlantic University
Subjects:
Online Access:http://purl.flvc.org/fau/fd/FA00013606

Similar Items